Anomalous glucose and insulin responses in patients with insulinoma. Caveats for diagnosis.

Two patients with insulinomas had unusual glucose and insulin-secretory dynamics in response to prolonged fasting. In patient 1, low insulin values persisted throughout three separate supervised fasts without a steady rise in the insulin-glucose ratio. In patient 2, a rising insulin-glucose ratio during a fast returned to normal after a documented catecholamine surge following a transient hypoglycemic episode. While patient 1 had clearly elevated proinsulin values of 52% to 57%, patient 2 had a near-normal value of 23%. The diagnosis of an insulinoma can usually be made by obtaining simultaneous glucose and insulin values during a prolonged supervised fast. Rarely, however, anomalous results may be obtained during supervised fasts of patients with insulinoma, and a broader range of diagnostic tests will be required to establish the correct diagnosis.

[1]  G. Lawrence,et al.  Metastatic insulinoma with long survival and glucagonoma syndrome. , 1984, Annals of internal medicine.

[2]  S. Taylor,et al.  Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats. , 1983, The Journal of clinical investigation.

[3]  P. Blackshear,et al.  Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus. , 1983, Annals of internal medicine.

[4]  G. Grunberger,et al.  Hypoglycemia associated with antibodies to the insulin receptor. , 1982, The New England journal of medicine.

[5]  C. Kahn,et al.  Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors. , 1981, The New England journal of medicine.

[6]  L. Landsberg,et al.  Adrenergic mechanisms in the metabolic adaptation to fasting and feeding: effects of phlorizin on diet-induced changes in sympathoadrenal activity in the rat. , 1980, Metabolism: clinical and experimental.

[7]  H. Kuzuya,et al.  C-peptide suppression test for insulinoma. , 1977, The Journal of laboratory and clinical medicine.

[8]  J. Roth,et al.  Insulin receptors in patients with insulinomas: changes in receptor affinity and concentration. , 1977, The Journal of clinical endocrinology and metabolism.

[9]  T. Merimee,et al.  Hypoglycemia in Man: Pathologic and Physiologic Variants , 1977, Diabetes.

[10]  E. Rayfield,et al.  Nonautonomous function of a pancreatic insulinoma. , 1976, The Journal of clinical endocrinology and metabolism.

[11]  Elveback Lr,et al.  Insulinoma: clinical and diagnostic features of 60 consecutive cases. , 1976, Mayo Clinic proceedings.

[12]  S. Fajans,et al.  Fasting hypoglycemia in adults. , 1976, The New England journal of medicine.

[13]  B. Faraj,et al.  Metabolism and disposition of diazoxide. A mini-review. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[14]  J. Gerber,et al.  Insulinoma with low circulating insulin levels: the diagnostic value of proinsulin measurements. , 1975, Annals of internal medicine.

[15]  P. Schein Islet cell tumors: current concepts and management. , 1973, Annals of internal medicine.

[16]  T. Danowski,et al.  Insulin and glucose patterns in control subjects and in proved insulinoma. , 1971, The American journal of the medical sciences.

[17]  S. Fajans,et al.  Circulating proinsulin-like material in patients with functioning insulinomas. , 1971, The New England journal of medicine.

[18]  I. Pastan,et al.  "Big insulin": a new component of plasma insulin detected by immunoassay. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Fajans,et al.  FURTHER STUDIES ON DIAZOXIDE SUPPRESSION OF INSULIN RELEASE FROM ABNORMAL AND NORMAL ISLET TISSUE IN MAN * , 1968, Annals of the New York Academy of Sciences.

[20]  D. Porte A receptor mechanism for the inhibition of insulin release by epinephrine in man. , 1967, The Journal of clinical investigation.